IWS
JAZZ icon

Intentional Wealth Strategies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Intentional Wealth Strategies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48
Closed -$9.07K – 496
2026
Q1 		$9.07K Buy
+48
New +$8.39K 0.01% 393

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Intentional Wealth Strategies's JAZZ Position: Q2 2026 in Review

Intentional Wealth Strategies sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 48 shares — an estimated $9.07K sold.

Intentional Wealth Strategies first reported a position in JAZZ in Q1 2026 and held it in 1 quarter. The position peaked at $9.07K in Q1 2026. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Intentional Wealth Strategies reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Intentional Wealth Strategies sold 48 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.07K.
  • Intentional Wealth Strategies first reported a position in Jazz Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Intentional Wealth Strategies's Jazz Pharmaceuticals position peaked at $9.07K in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Intentional Wealth Strategies's 13F filing for Q2 2026, filed 28 Jul 2026.